2022
DOI: 10.47750/pnr.2022.13.04.090
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of Neuregulin4 function in patients with polycystic ovary syndrome disorder

Abstract: Subject: Polycystic ovary syndrome (PCOS) is female disorder caused by cysts formation in ovarian that results disorder of hormones secretion and menstrual cycle. Neuregulin 4 (NRG4) is one of adipokines family members synthesis and release via adipose tissues, it acts as activator the epidermal growth factor receptor (EGFR).Objective of the Study: Assessment role of NRG4 in PCOS patients.Materials and Methods: Present study included 30 PCOS patients with 30 controls, the age individuals of tow group at study … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 4 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?